Skip to main content
. Author manuscript; available in PMC: 2012 Oct 15.
Published in final edited form as: J Neurol Sci. 2011 Jul 29;309(1-2):96–101. doi: 10.1016/j.jns.2011.07.008

Figure 1. Neurological outcome and lesion volume measurements after stroke.

Figure 1

Panels A-B show mNSS (A) and foot-fault (B) tests after stroke in the 4 experimental groups (MCAo control, tPA-10mg/kg, Niaspan-20mg/kg, and Combination treatment tPA and Niaspan treatment groups). Panel C shows the lesion volume in the 4 experimental groups. SE = standard error. *p< 0.05 vs MCAo.